![Ming Yi Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ms. Ming Yi Chen has over four years of venture capital related industry experience.
She is currently focused on ITIC’s biomedical practice and is primarily responsible for strategic planning, investment analysis, and other investment operations in the biomedical industry.
She also participates in fund raising activities.
Prior to joining ITIC, Ms. Chen specialized in investment evaluation, portfolio management and coordinated cross-border partnerships for Cheng Xin Technology Development Corp.
and FAT Capital Management.
She has also managed and exited several venture capital investments in the life science sector with exceptional returns.
Ms. Chen received a B.S.
from National Taiwan University, an M.S.
from Cornell University and an M.A. from Columbia University.
| Sociétés | Poste | Début |
|---|---|---|
| ANDROS PHARMACEUTICALS CO.,LTD | Directeur/Membre du Conseil | 27/06/2014 |
| Sociétés | Poste | Fin |
|---|---|---|
Industrial Technology Investment Corp.
 Industrial Technology Investment Corp. Investment ManagersFinance ITIC is an active manager which invests in innovative unlisted technology companies in a range of sectors including bandwidth improving software and hardware, multimedia application over Internet, Internet security, Internet infrastructure enabling technology, wireless information appliance, opto-electronics display, health care, medical devices and instruments and new energy. They invest primarily in Taiwan, but also invest in selected international areas such as the US, Canada and Israel. While the firm has historically focused on investing through in-house capital, they now extend their investment business to venture capital fund operations. They invest in all stages of a company's growth, although more in early-stage companies, seeking to add value to their investee companies by leveraging the resources of ITRI, incubating promising venture ideas, creating synergy among investee companies and co-investing with strategic partners. | Private Equity Investor | 04/03/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Industrial Technology Investment Corp.
Industrial Technology Investment Corp. Investment ManagersFinance ITIC is an active manager which invests in innovative unlisted technology companies in a range of sectors including bandwidth improving software and hardware, multimedia application over Internet, Internet security, Internet infrastructure enabling technology, wireless information appliance, opto-electronics display, health care, medical devices and instruments and new energy. They invest primarily in Taiwan, but also invest in selected international areas such as the US, Canada and Israel. While the firm has historically focused on investing through in-house capital, they now extend their investment business to venture capital fund operations. They invest in all stages of a company's growth, although more in early-stage companies, seeking to add value to their investee companies by leveraging the resources of ITRI, incubating promising venture ideas, creating synergy among investee companies and co-investing with strategic partners. | Finance |
Andros Pharmaceuticals Co., Ltd.
 Andros Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells novel drug delivery systems | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
